Search Results - "Sibley, C.H."

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    The Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trials by Commons, R.J., Thriemer, K., Humphreys, G., Suay, I., Sibley, C.H., Guerin, P.J., Price, R.N.

    “…Recurrent P. vivax infections are associated with significant morbidity and mortality. Although radical cure can reduce recurrent infection, it is confounded…”
    Get full text
    Journal Article
  2. 2

    Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance by Wongsrichanalai, C., Sibley, C.H.

    Published in Clinical microbiology and infection (01-10-2013)
    “…Following a decade-long scale up of malaria control through vector control interventions, the introduction of rapid diagnostic tests and highly efficacious…”
    Get full text
    Journal Article
  3. 3

    Genetic diversity of Plasmodium falciparum parasites from Kenya is not affected by antifolate drug selection by Nzila, A.M, Mberu, E.K, Nduati, E, Ross, A, Watkins, W.M, Sibley, C.H

    Published in International journal for parasitology (01-11-2002)
    “…The genotypes of merozoite surface protein-1, merozoite surface protein-2 and glutamine rich protein are frequently used to distinguish recrudescence from…”
    Get full text
    Journal Article
  4. 4

    A serine/threonine kinase activity is closely associated with a 65-kDa phosphoprotein specifically recognized by the kappa B enhancer element by OSTROWSKI, J, SIMS, J. E, SIBLEY, C. H, VALENTINE, M. A, DOWER, S. K, MEIER, K. E, BOMSZTYK, K

    Published in The Journal of biological chemistry (05-07-1991)
    “…The immunoglobulin kappa light chain enhancer, kappa B, is an important cis-acting transcriptional element. kappa B binds a number of proteins including the…”
    Get full text
    Journal Article